Joy Gibson, MD, PhD
Non-tuberculous mycobacteria, pulmonary infections, Cystic Fibrosis
Education
Albert Einstein College of Medicine
University of Colorado School of Medicine, Pediatrics
Children's Hospital Los Angeles, Pediatric Infectious Diseases
Accomplishments
General Pediatrics, American Board of Pediatrics
Publications
Gibson JE, Nandanwar N, Neely MN. Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence. Microbiol Spectr. 2024 Feb 6;12(2):e0322223. doi: 10.1128/spectrum.03222-23. Epub 2024 Jan 18. PubMed PMID: 38236037; PubMed Central PMCID: PMC10846206.
Nandanwar N, Gibson JE, Neely MN. Growth medium and nitric oxide alter Mycobacterium abscessus morphotype and virulence. Microbiol Res. 2021 Dec;253:126887. doi: 10.1016/j.micres.2021.126887. Epub 2021 Oct 5. PubMed PMID: 34628130.
Research
Dr. Gibson's laboratory is part of a unique collaborative group of researchers at CHLA, INSPIRE (innovative synergistic pediatric infection research), with Dr. Michael Neely and Dr. Elizabeth Burgener. Her laboratory seeks to optimize treatment regimens for challenging infections. Her primary focus is management of drug-resistant bacterial infections in patients with Cystic Fibrosis, particularly non-tuberculous mycobacteria. She utilizes a hollow fiber infection model to optimize current therapeutics and test novel treatment approaches in vitro.
